# OnCo record mabion (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/mabion/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "mabion" ;
  schema:name "Mabion"@en ;
  schema:alternateName "Mabion SA"@en, "Mabion S.A."@en ;
  schema:description "Mabion is a Polish biotech near Łódź that developed a rituximab biosimilar, MabionCD20, through phase 3 trials in lymphoma and rheumatoid arthritis, and now also manufactures biologics for partners."@en ;
  schema:url <https://onco.cc/companies/mabion/>, <https://www.mabion.eu> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.mabion.eu>, <https://clinicaltrials.gov/search?lead=Mabion%20SA>, <https://www.wikidata.org/wiki/Q19653276> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "PL" ;
  onco:cancers <https://onco.cc/cancers/dlbcl/> ;
  onco:drugs <https://onco.cc/drugs/rituximab/> ;
  onco:terms <https://onco.cc/terms/pivotal-trial/>, <https://onco.cc/terms/clinical-trial/>, <https://onco.cc/terms/biosimilar/> .